MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
22.06
+0.61
+2.84%
Opening 13:53 02/13 EST
OPEN
21.47
PREV CLOSE
21.45
HIGH
22.45
LOW
21.47
VOLUME
341.74K
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
18.80
MARKET CAP
906.67M
P/E (TTM)
47.30
1D
5D
1M
3M
1Y
5Y
1D
Pacira Biosciences Inc. to Report Financial Results and Host Conference Call
Reuters · 1d ago
Is Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Stock Price Struggling As A Result Of Its Mixed Financials?
Simply Wall St · 1d ago
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
Barchart · 1d ago
Pacira highlights new NOPAIN act survey data conducted by Voices
TipRanks · 1d ago
Pacira Biosciences Grants Inducement Equity Awards to New Employees
Reuters · 4d ago
Pacira Biosciences gewährt neuen Mitarbeitern Aktienoptionen und Restricted Stock Units als Anreiz
Reuters · 4d ago
PACIRA BIOSCIENCES REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 4d ago
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away
Seeking Alpha · 4d ago
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.